LAUSR

RVG29‐modified docetaxel‐loaded nanoparticles for brain‐targeted glioma therapy

Sign Up to like & get
recommendations!
0 Published in 2018 at "International Journal of Pharmaceutics"

DOI: 10.1016/j.ijpharm.2018.03.028

Abstract: &NA; Gliomas are the most common malignant brain tumor, but treatment is limited by the blood–brain barrier (BBB), especially for chemotherapeutic drugs. Although some chemotherapy drugs can pass through the BBB, many of these agents… read more here.

Keywords: rvg29 modified; brain; glioma therapy;